Correlation between A Body Shape Index and Target Organ Injury of Hypertension

LI Fangtang; YANG Xiaoli; CHEN Ruidan; YANG Yongjian

doi:10.12290/xhyxzz.2021-0332

Volume 13 Issue 1

Jan. 2022

Turn off MathJax

Article Contents

Abstract

References

Medical Journal of Peking Union Medical College Hospital > 2022 > 13(1): 82-88. > DOI: 10.12290/xhyxzz.2021-0332

LI Fangtang, YANG Xiaoli, CHEN Ruidan, YANG Yongjian. Correlation between A Body Shape Index and Target Organ Injury of Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 82-88. DOI: 10.12290/xhyxzz.2021-0332

Citation:

PDF (1248 KB)

Correlation between A Body Shape Index and Target Organ Injury of Hypertension

1.
Department of Cardiology, The General Hospital of Western Theater Command PLA Southwest Jiaotong University, Chengdu 610031, China
2.
Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing 400042, China

Funds:

National Natural Science Foundation of China General Program 81873477

More Information

Corresponding author:
YANG Yongjian, E-mail: yangyongjian38@sina.com
Received Date: April 13, 2021
Accepted Date: June 08, 2021
Available Online: January 27, 2022
Issue Publish Date: January 29, 2022

Graphical Abstract

Abstract

Abstract

Objective To explore the correlation between a body shape index (ABSI) and target organ injury in patients with hypertension.
Methods A cross-sectional study was used to collect related clinical indicators of patients with hypertension who were hospitalized in the Department of Cardiology, Daping Hospital, Third Military Medical University from March 2020 to January 2021. ASBI quantile method was used to divide the patients into low ASBI group, medium ASBI group and high ASBI group. Multiple Logistic regression was used to analyze the correlation between ASBI and target organ injury in patients with hypertension.
Results A total of 685 patients with hypertensive meeting the inclusion and exclusion criteria were enrolled, of which 445 had target organ damage; 229 cases were in the low ASBI group (ABSI≤0.076), 228 cases were in the medium ASBI group (0.076 < ABSI≤0.078), 228 cases were in the high ASBI group (ABSI > 0.078). The detection rate of left ventricular hypertrophy in the high ASBI group was higher than that in the low ASBI group(27.63% vs. 12.66%, P < 0.001). The detection rates of carotid atherosclerosis, and renal function impairment of the high ASBI group were higher than those of the medium ASBI group(39.04% vs. 26.32%, P=0.015;14.04% vs. 5.26%, P=0.007) and low ASBI group(39.04% vs. 25.76%, P=0.008;14.04% vs. 2.62%, P < 0.001). The multivariate Logistic regression analysis showed that ABSI was associated with increased left ventricular hypertrophy (OR=2.08, 95% CI: 1.24-3.50, P < 0.001) and renal injury (OR=6.47, 95% CI: 2.53-16.54, P < 0.001) in hypertensive patients.
Conclusion The increased ABSI is related to the prevalence of left ventricular hypertrophy and renal damage in hypertensive patients.
- a body shape index,
- hypertension,
- target organ injury,
- left ventricular hypertrophy,
- renal damage

FullText(HTML)

References (38)

References

[1]	Rothman KJ. BMI-related errors in the measurement of obesity[J]. Int J Obes (Lond), 2008, 32: S56-S59. DOI: 10.1038/ijo.2008.87
[2]	Messerli FH, Williams B, Ritz E. Essential hypertension[J]. Lancet, 2007, 370: 591-603. DOI: 10.1016/S0140-6736(07)61299-9
[3]	Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390: 2549-2558. DOI: 10.1016/S0140-6736(17)32478-9
[4]	Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index[J]. PLoS One, 2012, 7: e39504. DOI: 10.1371/journal.pone.0039504
[5]	Sato Y, Fujimoto S, Konta T, et al. Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population[J]. PLoS One, 2017, 12: e0177779. DOI: 10.1371/journal.pone.0177779
[6]	Cheung YB. "A Body Shape Index" in middle-age and older Indonesian population: scaling exponents and association with incident hypertension[J]. PLoS One, 2014, 9: e85421. DOI: 10.1371/journal.pone.0085421
[7]	中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24: 24-56. DOI: 10.3969/j.issn.1007-5410.2019.01.002 Writing Group of 2018 Chinese Guidelines for the Manage-ment of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al. 2018 Chinese guide-lines for the management of hypertension[J]. Zhongguo Xinxueguan Zazhi, 2019, 24: 24-56. DOI: 10.3969/j.issn.1007-5410.2019.01.002
[8]	吴雪怡, 马文君, 邹玉宝, 等. 血压昼夜节律与年轻高血压患者靶器官损伤的相关性[J]. 中国循环杂志, 2020, 35: 1103-1107. DOI: 10.3969/j.issn.1000-3614.2020.11.009 Wu XY, Ma WJ, Zou YB, et al. Association Between Blood Pressure Dipping Status and Target Organ Damage in Young Patients With Hypertension[J]. Zhongguo Xunhuan Zazhi, 2020, 35: 1103-1107. DOI: 10.3969/j.issn.1000-3614.2020.11.009
[9]	Cai W, Lang M, Jiang X, et al. Correlation among high salt intake, blood pressure variability, and target organ damage in patients with essential hypertension: Study protocol clinical trial (SPIRIT compliant)[J]. Medicine (Baltimore), 2020, 99: e19548. DOI: 10.1097/MD.0000000000019548
[10]	Gomez-Marcos MA, Gomez-Sanchez L, Patino-Alonso MC, et al. A body shape index and vascular structure and function in Spanish adults (MARK study): A cross-sectional study[J]. Medicine (Baltimore), 2018, 97: e13299. DOI: 10.1097/MD.0000000000013299
[11]	Jänne PA, Ou SI, Kim DW, et al. Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial[J]. Lancet Oncol, 2014, 15: 1433-1441. DOI: 10.1016/S1470-2045(14)70461-9
[12]	杨月欣, 张环美. 《中国居民膳食指南(2016)》简介[J]. 营养学报, 2016, 38: 209-217. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXX201603003.htm Yang YX, Zhang HM. Introduction to the Dietary Guidelines for Chinese Residents (2016)[J]. Yingyang Xuebao, 2016, 38: 209-217. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXX201603003.htm
[13]	孙晓静, 林海燕, 李晓红. 37160例健康体检者血脂异常结果分析[J]. 山东医药, 2020, 60: 78-81. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202019021.htm Sun XJ, Lin HY, Li XH. Analysis of the results of dyslipidemia in 37160 healthy subjects[J]. Shandong Yiyao, 2020, 60: 78-81. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202019021.htm
[14]	许顶立, 任昊. 高血压病肾脏损害的诊断与防治[J]. 中华心血管病杂志, 2004, 32: 98-100. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHXX200402034.htm Xu DL, Ren H. Diagnosis and prevention of renal damage in hypertension[J]. Zhonghua Xinxueguanbing Zazhi, 2004, 32: 98-100. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHXX200402034.htm
[15]	Chen TK, Estrella MM, Astor BC, et al. Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK)[J]. Nephrol Dial Transplant, 2015, 30: 1329-1335. DOI: 10.1093/ndt/gfv037
[16]	Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41: 407-477. DOI: 10.1093/eurheartj/ehz425
[17]	Wang Z, Chen Z, Zhang L, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012—2015[J]. Circulation, 2018, 137: 2344-2356. DOI: 10.1161/CIRCULATIONAHA.117.032380
[18]	Hall JE, do Carmo JM, da Silva AA, et al. Obesity, kidney dysfunction and hypertension: mechanistic links[J]. Nat Rev Nephrol, 2019, 15: 367-385.
[19]	Wang L, Wang H, Zhang B, et al. Elevated Fat Intake Increases Body Weight and the Risk of Overweight and Obesity among Chinese Adults: 1991—2015 Trends[J]. Nutrients, 2020, 12: 3272. DOI: 10.3390/nu12113272
[20]	Hu L, Huang X, You C, et al. Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China[J]. PLoS One, 2017, 12: e0170238. DOI: 10.1371/journal.pone.0170238
[21]	Bozorgmanesh M, Sardarinia M, Hajsheikholeslami F, et al. CVD-predictive performances of "a body shape index" versus simple anthropometric measures: Tehran lipid and glucose study[J]. Eur J Nutr, 2016, 55: 147-157. DOI: 10.1007/s00394-015-0833-1
[22]	Bouchi R, Asakawa M, Ohara N, et al. Indirect measure of visceral adiposity 'A Body Shape Index' (ABSI) is associated with arterial stiffness in patients with type 2 diabetes[J]. BMJ Open Diabetes Res Care, 2016, 4: e000188. DOI: 10.1136/bmjdrc-2015-000188
[23]	Dhana K, Kavousi M, Ikram MA, et al. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality[J]. J Epidemiol Community Health, 2016, 70: 90-96. DOI: 10.1136/jech-2014-205257
[24]	Bawadi H, Abouwatfa M, Alsaeed S, et al. Body Shape Index Is a Stronger Predictor of Diabetes[J]. Nutrients, 2019, 11: 1018. DOI: 10.3390/nu11051018
[25]	Ji M, Zhang S, An R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis[J]. Obes Rev, 2018, 19: 737-759. DOI: 10.1111/obr.12666
[26]	Leone A, Vizzuso S, Brambilla P, et al. Evaluation of Different Adiposity Indices and Association with Metabolic Syndrome Risk in Obese Children: Is there a Winner?[J]. Int J Mol Sci, 2020, 21: 4083. DOI: 10.3390/ijms21114083
[27]	Bertoli S, Leone A, Krakauer NY, et al. Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults[J]. PLoS One, 2017, 12: e0185013. DOI: 10.1371/journal.pone.0185013
[28]	Geraci G, Zammuto M, Gaetani R, et al. Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension[J]. Nutr Metab Cardiovasc Dis, 2019, 29: 822-829. DOI: 10.1016/j.numecd.2019.04.013
[29]	Chang Y, Guo X, Li T, et al. A Body Shape Index and Body Roundness Index: Two New Body Indices to Identify left Ventricular Hypertrophy among Rural Populations in Northeast China[J]. Heart Lung Circ, 2016, 25: 358-364. DOI: 10.1016/j.hlc.2015.08.009
[30]	Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism[J]. Circulation, 2006, 113: 898-918. DOI: 10.1161/CIRCULATIONAHA.106.171016
[31]	Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk[J]. Arterioscler Thromb Vasc Biol, 2008, 28: 1039-1049. DOI: 10.1161/ATVBAHA.107.159228
[32]	Pagé A, Dumesnil JG, Clavel MA, et al. Metabolic syndr-ome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin)[J]. J Am Coll Cardiol, 2010, 55: 1867-1874. DOI: 10.1016/j.jacc.2009.11.083
[33]	Capoulade R, Clavel MA, Dumesnil JG, et al. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial[J]. JACC Cardiovasc Imaging, 2013, 6: 165-174.
[34]	Kawarazaki W, Fujita T. The Role of Aldosterone in Obesity-Related Hypertension[J]. Am J Hypertens, 2016, 29: 415-423. DOI: 10.1093/ajh/hpw003
[35]	Foster MC, Hwang SJ, Porter SA, et al. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study[J]. Hypertension, 2011, 58: 784-790. DOI: 10.1161/HYPERTENSIONAHA.111.175315
[36]	Abete I, Arriola L, Etxezarreta N, et al. Association bet-ween different obesity measures and the risk of stroke in the EPIC Spanish cohort[J]. Eur J Nutr, 2015, 54: 365-375. DOI: 10.1007/s00394-014-0716-x
[37]	Wang GL, Zhang R, Zhou YT, et al. Combined Effects of A Body Shape Index and Serum C-reactive Protein on Ischemic Stroke Incidence among Mongolians in China[J]. Biomed Environ Sci, 2019, 32: 169-176.
[38]	Wang F, Chen Y, Chang Y, et al. New anthropometric indices or old ones: which perform better in estimat-ing cardiovascular risks in Chinese adults[J]. BMC Cardiovasc Disord, 2018, 18: 14. DOI: 10.1186/s12872-018-0754-z

[1]	ZHAO Ying, XU Yingchun. Research Progress on Novel Antimicrobial Susceptibility Testing Methods[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1137-1145. DOI: 10.12290/xhyxzz.2024-0001
[2]	CHEN Chen, WU Ying, HUA Xian, LU Jinnan, LI Yi, ZHAO Chunhua, MIN Han. Influence of Host Factors on Drug Resistance of Helicobacter Pylori Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1091-1099. DOI: 10.12290/xhyxzz.2024-0011
[3]	WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 616-623. DOI: 10.12290/xhyxzz.2023-0454
[4]	LI Linrong, LI Yan, SUN Qiang. Clinical Trials and Current Progress in the Treatment of Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 177-183. DOI: 10.12290/xhyxzz.2022-0085
[5]	ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
[6]	Qing-lin LI, Yu-qing ZHANG. Renal Sympathetic Denervation in the Treatment of Resistant Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 6-11. DOI: 10.3969/j.issn.1674-9081.20190251
[7]	Xiao-jiang ZHANG, Hui ZHANG, Qi-wen YANG, Yao WANG, He WANG, Hong-li SUN, Wen-jing LIU, Li ZHANG, Ying ZHAO, Ya-li LIU, Li-na GUO, Hong-tao DOU, Meng XIAO, Ying-chun XU. Changes of Antibiotic Resistance of Clinically Important Bacteria that World Health Organization is Concerned about: 10-Year Data Analysis of Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 48-53. DOI: 10.3969/j.issn.1674-9081.2018.01.010
[8]	Yun LONG, Qing-hua GUO, Da-wei LIU, Xiao-jiang ZHANG, Lian-yan SONG, Huai-wu HE. Risk Factors and Clinical Outcomes of Pan-drug Resistant Acinetobacter baumannii Bacteremia[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(4): 260-266. DOI: 10.3969/j.issn.1674-9081.2015.04.005
[9]	Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
[10]	Xin FAN, Meng XIAO, Qi-wen YANG, Hong-tao DOU, Li-na GUO, He WANG, Ying YUAN, Peng WANG, Ying ZHAO, Qi ZHANG, Yong-hong XIAO, Ying-chun XU. Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(3): 253-258. DOI: 10.3969/j.issn.1674-9081.2014.03.002

Cited By

Get Citation

PDF

XML

Article Metrics

Article views PDF downloads

Address：	Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
Tel：	010-69154261/4262
E - mail：	medj@pumch.cn mjpumch@126.com
Copyright of website：	Editorial Office of Medical Journal of Peking Union Medical College Hospital

Correlation between A Body Shape Index and Target Organ Injury of Hypertension

Abstract

References

Related Articles

Catalog

Article Metrics

Related

Correlation between A Body Shape Index and Target Organ Injury of Hypertension

Abstract

References

Related Articles

Catalog

Article Metrics

Related

Export File

Citation

Format

Content